Pilot Study of Daily 3-Minute Hand-Held Vibration Therapy to Improve Chemotherapy-Induced Peripheral Neuropathy in Hands

What this Trial Is About

Researchers are evaluating the safety and feasibility of a daily 3-minute hand-held vibration therapy to reduce the severity of chemotherapy-induced peripheral neuropathy CIPN in the hands. This pilot study aims to gather early data on the feasibility, safety, and potential benefits of this therapy to improve CIPN-related quality of life. The goal is to use these results to support future trials exploring vibration therapy as a treatment option for CIPN. Participants will use a hand-held vibrating device daily, holding it on each hand for 3 minutes over a 4-week period. This intervention is designed to be simple and self-administered. There are no comparator groups mentioned, and the focus is on monitoring the therapys acceptability and compliance during this time. During the study, researchers will track recruitment rates, adherence to therapy sessions, and patient acceptance of the intervention. They will measure changes in CIPN severity and quality of life using validated questionnaires at baseline and weekly throughout the 4 weeks, with additional follow-ups up to 8 weeks. Participants must return to the clinic for assessments at specified intervals to support these evaluations.

Daily Hand-Held Vibration Therapy